The Risk of Actos May Be Greater Than You Think
Pioglitazone treatments, commonly distributed through the prescription medication Actos, has been shown to substantially increase the risk of bladder cancer for some patients. In particular, the risk of cancer increased sharply as duration and dose rose. In fact, compared to never being exposed to pioglitazone, a pioglitazone therapy longer than 12 months was associated with a 40 percent increase in cancer risk.
Even Actos patients who know that pioglitazone treatments may increase their cancer risk don’t necessarily understand precisely how much that risk may elevate. To make informed decisions, full disclosure by the manufacturer and complete understanding by the patient are essential. If you or a loved one have been taking Actos without a complete understanding of Actos’s considerable cancer risk, your rights may have been violated.
The attorneys at Fears Nachawati are committed to using the legal system to protect patients against the risks and harms of dangerous drugs like Actos. You deserve the chance to make informed choices about your future. Want to find out more about how our firm’s expert, experienced lawyers can help you? Call today for your free consultation. Just call 1.866.545.8364 or email email@example.com. Let us help you and your family.